<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38103017</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Long COVID during the Omicron predominant waves among Japanese healthcare workers.</ArticleTitle><Pagination><StartPage>e29322</StartPage><MedlinePgn>e29322</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29322</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yunfei</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0542-4641</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6503-8577</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horii</LastName><ForeName>Kumi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Infection Control Office, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizoue</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konishi</LastName><ForeName>Maki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugiyama</LastName><ForeName>Haruhito</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugiura</LastName><ForeName>Wataru</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohmagari</LastName><ForeName>Norio</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>National Center for Global Health and Medicine</Agency><Country/></Grant><Grant><Agency>Japan Health Research Promotion Bureau</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>16</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>16</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38103017</ArticleId><ArticleId IdType="doi">10.1002/jmv.29322</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi:10.1016/j.eclinm.2022.101762</Citation></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al. Risk factors associated with post&#x2212;COVID-19 condition: a systematic review and meta-analysis. JAMA Internal Med. 2023;183:566. doi:10.1001/jamainternmed.2023.0750</Citation></Reference><Reference><Citation>Nehme M, Vetter P, Chappuis F, et al. Prevalence of post-coronavirus disease condition 12 weeks after Omicron infection compared with negative controls and association with vaccination status. Clin Infect Dis. 2023;76(9):1567-1575. doi:10.1093/cid/ciac947</Citation></Reference><Reference><Citation>Arjun MC, Singh AK, Roy P, et al. Long COVID following Omicron wave in Eastern India-a retrospective cohort study. J Med Virol. 2023;95(1):e28214. doi:10.1002/jmv.28214</Citation></Reference><Reference><Citation>Qasmieh SA, Robertson MM, Teasdale CA, et al. The prevalence of SARS-CoV-2 infection and long COVID in US&#xa0;adults during the BA.4/BA.5 surge, June-July 2022. Prev Med. 2023;169:107461. doi:10.1016/j.ypmed.2023.107461</Citation></Reference><Reference><Citation>Centers for Diseases Control and Prevention. Long COVID or post-COVID conditions.&#xa0;2022. Accessed November 4, 2022.&#xa0;https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102-111. doi:10.1016/j.ijid.2022.12.036</Citation></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus Omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263-2264. doi:10.1016/s0140-6736(22)00941-2</Citation></Reference><Reference><Citation>Rochmawati E, Iskandar AC, Kamilah F. Persistent symptoms among post-COVID-19 survivors: a systematic review and meta-analysis. J Clin Nurs. 2022:1-11. doi:10.1111/jocn.16471</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>